Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

10x Genomics, Inc. - Common Stock (NQ:TXG)

21.58 -0.47 (-2.15%)
Streaming Delayed Price Updated: 10:07 AM EST, Jan 21, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about 10x Genomics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
News headline image
3 Hyped Up Stocks That Concern Us
The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial... 
Via StockStory
News headline image
1 Healthcare Stock to Consider Right Now and 2 We Find Risky
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Players catalyzing medical advancements have benefited from elevated demand, and... 
Via StockStory
Topics Stocks
News headline image
1 Cash-Heavy Stock to Consider Right Now and 2 We Question
A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion opportunities, or inconsistent cash flow. 
Via StockStory
News headline image
Why 10x Genomics (TXG) Shares Are Falling Today
Shares of biotech company 10x Genomics (NASDAQ:TXG) fell 4.7% in the afternoon session after the company announced weak preliminary results for its fourth quarter and full year 2025, which pointed to a... 
Via StockStory
Topics Intellectual Property
News headline image
Earnings Scheduled For November 6, 2025 ↗
 
Via Benzinga
News headline image
10x Genomics (TXG) Stock Is Up, What You Need To Know
Shares of biotech company 10x Genomics (NASDAQ:TXG) jumped 2.5% in the afternoon session after several analysts raised their price targets on the stock, pointing to a more optimistic outlook for the... 
Via StockStory
Topics Artificial Intelligence
News headline image
2 Russell 2000 Stocks Worth Investigating and 1 We Avoid
The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However, these companies often come with higher... 
Via StockStory
News headline image
10x Genomics (TXG) Stock Trades Up, Here Is Why
Shares of biotech company 10x Genomics (NASDAQ:TXG) jumped 4.8% in the morning session after Canaccord Genuity maintained its 'Buy' rating and raised its price target on the company's shares. 
Via StockStory
Topics Artificial Intelligence
News headline image
1 Stock Under $50 Worth Your Attention and 2 We Turn Down
Stocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than penny stocks. But their headline prices don’t guarantee quality, and... 
Via StockStory
News headline image
10x Genomics (TXG) Q2 2025 Earnings Transcript ↗
10x Genomics (TXG) Q2 2025 Earnings Transcript 
Via The Motley Fool
Topics Intellectual Property World Trade
News headline image
10x Genomics (TXG) Q4 2024 Earnings Transcript ↗
10x Genomics (TXG) Q4 2024 Earnings Transcript 
Via The Motley Fool
News headline image
Why 10x Genomics (TXG) Stock Is Nosediving
Shares of biotech company 10x Genomics (NASDAQ:TXG) fell 6.3% in the morning session after Citigroup downgraded the stock to Neutral from Buy. 
Via StockStory
Topics Government
News headline image
Life Sciences Tools & Services Stocks Q3 Earnings: 10x Genomics (NASDAQ:TXG) Firing on All Cylinders
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how life sciences tools & services stocks fared in Q3, starting... 
Via StockStory
Topics Artificial Intelligence
News headline image
3 Unprofitable Stocks with Questionable Fundamentals
Running at a loss can be a red flag. Many of these businesses face mounting challenges as competition increases and funding becomes harder to secure. 
Via StockStory
News headline image
10x Genomics (TXG) Q3 2025 Earnings Transcript ↗
10x Genomics (TXG) Q3 2025 Earnings Transcript 
Via The Motley Fool
News headline image
BrightSpring Health Services, 10x Genomics, QuidelOrtho, Medpace, and Fortrea Shares Are Soaring, What You Need To Know
A number of stocks jumped in the afternoon session after reports revealed the Trump administration considered extending the Affordable Care Act (ACA) subsidies. These subsidies, which are government... 
Via StockStory
Topics Economy Government
News headline image
Bruker, 10x Genomics, PacBio, ICU Medical, and Dentsply Sirona Shares Skyrocket, What You Need To Know
A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated... 
Via StockStory
Topics Economy
News headline image
3 Reasons to Avoid TXG and 1 Stock to Buy Instead
What a time it’s been for 10x Genomics. In the past six months alone, the company’s stock price has increased by a massive 73.9%, reaching $15.53 per share. This was partly thanks to its solid... 
Via StockStory
News headline image
1 Momentum Stock with Promising Prospects and 2 We Avoid
Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of positive catalysts such as a new product line, constructive news flow, or... 
Via StockStory
News headline image
5 Insightful Analyst Questions From 10x Genomics’s Q3 Earnings Call
10x Genomics delivered results in Q3 that exceeded Wall Street’s expectations, driven by robust demand in spatial biology and a steady performance in single-cell consumables. Management attributed the... 
Via StockStory
Topics Earnings
News headline image
1 Small-Cap Stock for Long-Term Investors and 2 We Avoid
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small... 
Via StockStory
News headline image
Why 10x Genomics (TXG) Stock Is Trading Up Today
Shares of biotech company 10x Genomics (NASDAQ:TXG) jumped 0.6% in the afternoon session after Canaccord Genuity Group raised its price target on the stock. The analyst firm lifted its target to $19.00... 
Via StockStory
Topics Artificial Intelligence Supply Chain
News headline image
Spotting Winners: PacBio (NASDAQ:PACB) And Life Sciences Tools & Services Stocks In Q3
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at PacBio (NASDAQ:PACB) and the best and worst... 
Via StockStory
Topics Artificial Intelligence
News headline image
3 Russell 2000 Stocks We Approach with Caution
The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size also means these businesses often lack the... 
Via StockStory
Topics Retirement
News headline image
Why 10x Genomics (TXG) Stock Is Trading Up Today
Shares of biotech company 10x Genomics (NASDAQ:TXG) jumped 14.3% in the afternoon session after the company reported third-quarter financial results that beat Wall Street's expectations and provided an... 
Via StockStory
Topics Artificial Intelligence
News headline image
TXG Q3 Deep Dive: Spatial Biology and Consumables Drive Outperformance Amid Macro Uncertainty
Biotech company 10x Genomics (NASDAQ:TXG) beat Wall Street’s revenue expectations in Q3 CY2025, but sales fell by 1.7% year on year to $149 million. On top of that, next quarter’s revenue guidance... 
Via StockStory
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
10X Genomics (NASDAQ:TXG) Surges 13% on Q3 Revenue Beat and Strong Guidance ↗
10x Genomics (TXG) stock surged over 13% after beating Q3 2025 earnings estimates and providing strong Q4 revenue guidance, signaling investor optimism. 
Via Chartmill
News headline image
10x Genomics’s (NASDAQ:TXG) Q3: Strong Sales, Stock Jumps 13.1%
Biotech company 10x Genomics (NASDAQ:TXG) reported Q3 CY2025 results beating Wall Street’s revenue expectations, but sales fell by 1.7% year on year to $149 million. On top of that, next quarter’s... 
Via StockStory
News headline image
Mark Zuckerberg’s Chan Zuckerberg Initiative Bets Big on AI to Conquer All Diseases
The Chan Zuckerberg Initiative (CZI), founded by Priscilla Chan and Mark Zuckerberg, is placing artificial intelligence at the very heart of its audacious mission: to cure, prevent, or manage all... 
Via TokenRing AI
Topics Artificial Intelligence
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.